Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Press conference, June 30: Polygiene ViralOff – from launch to category leader in 3 months

We would like to invite you to our orientation on ViralOff®, an opportunity to give you essential information and updates. Polygiene CMO and PhD Mats Georgson will present the big picture, several new developments and launches. In addition, we will also look at the intricacies and importance of global testing parameters surrounding viruses and of course, Covid-19 in particular. The key concept here is pandemic sustainability – taking care of both viruses as well as the planet means being tough on the former but nice to the latter. We look forward to having you there! Start

Moberg Pharma meets primary endpoint in the European Phase 3 study

STOCKHOLM, June 25[th], 2020, Moberg Pharma AB (OMX: MOB) announces that MOB-015 (topical terbinafine) met the primary endpoint in the European Phase 3 study including 452 onychomycosis patients, showing non-inferiority versus topical ciclopirox. Mycological cure was achieved in 84 percent of patients, which is unprecedented for a topical treatment and even higher than reported for oral treatments. The pattern is consistent with the results from the North American Phase 3 study, with low complete cure rates despite the high mycological cure rates. Moberg Pharma will discuss next steps with

Sedana Medical expands in Eastern Europe – signs distribution agreements

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that it has signed agreements with distributors in Bulgaria, Cyprus, Greece, Slovakia and the Czech Republic. The agreements are part of the preparations ahead of the registration of the drug candidate IsoConDa, which is expected next year.“We highly appreciate the great interest there is in launching and selling AnaConDa in the markets we do not cover ourselves. Through this expansion of our distributor network, we are strengthening the position ahead of the upcoming market launch of our therapy,” said Christer Ahlberg, CEO of

Aker ASA: Aker BioMarine AS – Successful completion of private placement

NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, HONG KONG, SOUTH AFRICA OR ANY JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OF LOCAL SECURITIES LAWS OR REGULATIONS. Reference is made to the announcement published on 19 June 2020, regarding the private placement of new shares (the “Private Placement”) in Aker BioMarine AS (the "Company"). The application period for the Private Placement expired at 16:30 CEST on 24 June 2020 after the application period was shortened as announced on 23 June 2020.

RepRisk partners with Battlefin to offer ESG datasets for the alternative data community

The world’s largest dataset on ESG and business conduct risk is now available as part of BattleFin’s alternative data suite of solutionsZurich, Switzerland, and London, UK – June 25, 2020 – RepRisk, a pioneer and leader in ESG data science combining machine learning and human intelligence, has formed a strategic partnership with alternative data platform and marketplace BattleFin that will significantly expand alternative data buyer access to ESG risk data.   RepRisk’s daily-updated dataset on nearly 150,000 companies linked to ESG and business conduct risks will be available through

Filo Mining Outlines Potential to Significantly Expand the Current Filo del Sol Resource

VANCOUVER, JUNE 25, 2020 /CNW/: Filo Mining Corp. (TSXV, Nasdaq First North Growth Market: FIL) ("Filo Mining”, or the “Company”) is pleased to provide a summary of the results of the recently completed 2019/2020 field program at the Filo del Sol project, and to discuss the implications of these results for the ultimate size of this impressive mineral system. Commenting on the recent results, President and CEO Jamie Beck stated, “Our latest drill program has transformed our understanding of the size and scale of the Filo system. Standout results include two of the best copper-gold

Lundin Gold Announces Voting Results from Annual Meeting

June 24, 2020 (Vancouver, Canada) /CNW/ Lundin Gold Inc. ("Lundin Gold" or the "Company") (TSX: LUG, Nasdaq Stockholm: LUG) is pleased to report the voting results from the Company’s 2020 Annual General Meeting of Shareholders (“Annual Meeting”), which was held earlier today in Vancouver, British Columbia.  Election of Directors The ten nominees listed in the management proxy circular for the Annual Meeting were elected as directors of the Company. The detailed results of the vote for the election of directors held at the Annual Meeting are set out below. +--------------------+-----

Leading Edge Materials Reports Quarterly Results to April 30, 2020

Vancouver, BC, June 24, 2020 /CNW/ – Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) announces second quarter results for the period ending April 30, 2020. All references to dollar amounts in this release are in Canadian dollars.  Three Months Ended April 30, 2020 Compared to Three Months Ended January 31, 2020During the three months ended April 30, 2020 (“Q2”) the Company reported a net loss of $317,422 compared to a net loss of $407,304 for the three months ended January 31, 2020 (“Q1”), a decrease in

Citigroup notifies that stabilization measures have been undertaken in Calliditas Therapeutics' ADSs traded on The Nasdaq Global Select Market

Citigroup Global Markets Inc. ("Citigroup"), in its capacity as Joint Global Coordinator, notifies that stabilization measures have been undertaken in Calliditas Therapeutics AB's (”Calliditas” or the “Company”) American Depositary Shares ("ADSs"), traded on The Nasdaq Global Select Market.As announced by the Company in connection with the initial public offering on The Nasdaq Global Select Market, by way of a capital increase of new common shares in the form of ADSs, each representing two (2) underlying new common shares of Calliditas, (the "U.S. Offering"), and a concurrent private

Observe Medical ASA – Investor presentations in connection with the rights issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS STOCK EXCHANGE ANNOUNCEMENT. Observe Medical ASA is conducting a range of investor meetings in connection with the ongoing rights issue. Presentation material for the meetings follows enclosed. Investors are welcome to join group

Photocure ASA – Private placement successfully placed

NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OF AMERICA AND THE DISTRICT OF COLUMBIA) (THE "UNITED STATES"), AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.Oslo, Norway, 24 June 2020: Reference is made to the stock exchange notice earlier today where Photocure ASA ("Photocure" or the "Company") announced

Chairman taken into custody

Earlier today, Brighter announced that the company's chairman today, on June 24, has been picked up by the Economic Crime Authority for questioning. The prosecutor in charge, Jonas Myrdal, has confirmed that the person is held under custody and that a preliminary investigation has been initiated. At the same time, we currently have very limited information on the matter. Now we have to wait and see what the investigation shows. For further information, please contact: Henrik Norström, CEO+46 733 40 30 45ir@brighter.se Certified AdviserBrighter’s Certified Adviser is

Leading Edge Materials Annual General Meeting of Shareholders to be Held Friday, July 24, 2020

VANCOUVER, June 24, 2020 /CNW/ - Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) announces that its Annual General Meeting of Shareholders (the “Meeting”) will be held at Suite 1305 – 1090 West Georgia Street, Vancouver, British Columbia, V6E 3V7 on Friday, July 24, 2020, at 10:00 am (Vancouver Time), for the following purposes:  1. to receive the Chief Executive Officer’s Report to the Shareholders of the Company; 2. to receive and consider the financial statements of the Company as at and for the year

Swedencare AB (publ) completes a directed new share issue of 1,500,000 new shares, raising proceeds of approximately SEK 133 million to finance the Stratford acquisition

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE. The board of directors of Swedencare AB (publ) (”Swedencare” or the ”Company”) has, in accordance with the Company’s press release earlier today, resolved on and carried out a new

Updated information by reason of alleged insider trading

The two senior executives Marcus Hansson and Magnus Björndahl were released on Wednesday evening. For additional information, please contact:CEO Erik Selin, phone +46 706 07 47 90 orHead of Communications Sandra Nilsson, phone +46 31 10 95   Fastighets AB Balder is a listed real estate company which shall meet the needs of different customer groups for premises and housing through local support. Balder's real estate portfolio had a value of SEK 151.2 billion (123.2) as of 31 March 2020. The Balder share is listed on Nasdaq Stockholm, Large Cap. Fastighets AB Balder (publ)

Aker Solutions Awarded Letter of Intent for Breidablikk

June 24, 2020 - Aker Solutions has been awarded a letter of intent from Equinor for the delivery of a subsea system for the Breidablikk project in the North Sea. The scope of work covers a complete subsea production system, and associated equipment that includes 15 subsea trees in the first phase. "We are delighted to be awarded a letter of intent by Equinor, which will lead to more activity at many of our facilities in Norway and beyond," said Luis Araujo, chief executive officer of Aker Solutions. The work will be carried out at Aker Solutions' locations in Fornebu, Tranby

Rare Summer Specials at California Inns

SACRAMENTO, CA [June 24, 2020]—Following three months of sheltering-in-place, California boutique hotels and bed and breakfast inns are cautiously beginning to reopen their doors in select regions around the state.  To encourage travelers, some inns are offering rare specials for the summer season. Eden Vale InnIn Placerville, the lush gardens and luxurious accommodations of Eden Vale Inn  are beckoning travelers for a restorative getaway with savings up to $100.  Book a two-night stay in any room or suite now through August 31, 2020 and save $50 off each

Serneke received consent from the bondholders in the written procedure to amend the terms and conditions and extend the maturity of its senior unsecured bonds 2018/2021

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES (INCLUDING ITS TERRITORIES AND POSSESSIONS) OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933), AUSTRALIA, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, SWITZERLAND, SINGAPORE OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES. Serneke Group AB (publ), reg. no. 556669-4153, (the “Company”) today announces that the written procedure initiated on 4 June 2020

Swedencare AB (publ) intends to carry out a directed new share issue as part of the financing of the acquisition of the business conducted by Stratford Pharmaceuticals, LLC

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE. Swedencare AB (publ) (”Swedencare” or the ”Company”) today announces its intention to carry out a directed new share issue of up to 1,500,000 new shares to Swedish and international

Swedencare AB (publ) announce new CEO after strategic acquisition

The Board of Directors of Swedencare AB (publ) have today assigned Håkan Lagerberg to new CEO, former CEO Jenny Graflind will at the same time return as Group CFOHåkan Lagerberg assumes his position as CEO today, on June 24th. The background to the management changes is the strategic acquisition announced earlier today. “My board colleagues and I want to thank Jenny for a job well done as CEO during a period where the focus was on expanding the market initiatives around the ProDen PlaqueOff® product family. As we now carry out a strategic acquisition and at the same time continue to

Swedencare AB (publ) acquires the operations of leading American company in Animal Health care products

Swedencare AB (publ) ("Swedencare") acquires the business conducted by the American animal health company Stratford Pharmaceuticals, LLC ("Stratford"). The purchase price amounts to approximately SEK 159,3 million and will be paid through a cash settlement upon closing, which is expected to take place on July 1st, 2020. Through the acquisition Swedencare will receive a comprehensive product portfolio of supplements in the premium segment for dogs and cats. The products are currently sold to approximately 10,000 veterinary clinics in the United States, partly through a unique co-branding

EAB GROUP PLC: ACQUISITION OF OWN SHARES 24.06.2020

EAB GROUP PLC NOTIFICATION 24.06.2020 at 18:30 EAB GROUP PLC: ACQUISITION OF OWN SHARES 24.06.2020 Date 24.06.2020Exchange transaction BuyShare class EABAmount 140Average price/share 2.1200 EURHighest price/share 2.1200 EURLowest price/share 2.1200 EURTotal price 296.80 EUR The shares held by EAB Group Plc on 24.06.2020: EAB 26,137 On behalf of EAB Group Plc  Skandinaviska Enskilda Banken AB (Publ) Antti Salakka         Mikko Virtanen For more information, please

American Shipping Company ASA: Purchase of Treasury Shares

Reference is made to American Shipping Company ASA’s (“American Shipping Company” or “Company”) stock exchange notice on 23 June 2020 where the Company announced its intention to purchase up to 52,000 treasury shares in connection with its incentive program for employees. American Shipping Company has on 24 June 2020 purchased 37,508 shares in the Company on the Oslo Stock Exchange at an average price of NOK 25.3229 per share, which implies a total consideration of NOK 949,811. The purchase of treasury shares was carried out in accordance with an authorization granted by the Annual General

Recipharm announces the preliminary outcome of the oversubscribed rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE SECTION “IMPORTANT INFORMATION” AT THE END OF THIS PRESS RELEASE. The preliminary result of the rights issue in Recipharm AB (publ) (“Recipharm” or the “Company”), for which the subscription period ended on 22 June 2020, shows that the rights issue is

There are no items matching the current filter
There are no more items matching the current filter
Back to top